|
||||||||||||||||||||
| |
| Phenotypic Information (metabolism pathway, cancer, disease, phenome) |
| |
| |
| Gene-Gene Network Information: Co-Expression Network, Interacting Genes & KEGG |
| |
|
| Gene Summary for DTYMK |
| Top |
| Phenotypic Information for DTYMK(metabolism pathway, cancer, disease, phenome) |
 Cancer Description | |
| Cancer | CGAP: DTYMK |
| Familial Cancer Database: DTYMK | |
| * This gene is included in those cancer gene databases. |
|
|
|
|
|
| . | ||||||||||||||
Oncogene 1 | Significant driver gene in | |||||||||||||||||||
| cf) number; DB name 1 Oncogene; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 2 Tumor Suppressor gene; https://bioinfo.uth.edu/TSGene/, 3 Cancer Gene Census; http://www.nature.com/nrc/journal/v4/n3/abs/nrc1299.html, 4 CancerGenes; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 5 Network of Cancer Gene; http://ncg.kcl.ac.uk/index.php, 1Therapeutic Vulnerabilities in Cancer; http://cbio.mskcc.org/cancergenomics/statius/ |
| Metabolic Pathway Description | |
| KEGG_PYRIMIDINE_METABOLISM REACTOME_METABOLISM_OF_NUCLEOTIDES | |
| Others | |
| OMIM | |
| Orphanet | |
| Disease | KEGG Disease: DTYMK |
| MedGen: DTYMK (Human Medical Genetics with Condition) | |
| ClinVar: DTYMK | |
| Phenotype | MGI: DTYMK (International Mouse Phenotyping Consortium) |
| PhenomicDB: DTYMK | |
| Mutations for DTYMK |
| * Under tables are showing count per each tissue to give us broad intuition about tissue specific mutation patterns.You can go to the detailed page for each mutation database's web site. |
| Structural Variants in COSMIC: go to COSMIC mutation histogram |
| There's no structural variation information in COSMIC data for this gene. |
| Related fusion transcripts : go to Chitars2.0 |
| * From mRNA Sanger sequences, Chitars2.0 arranged chimeric transcripts. This table shows DTYMK related fusion information. |
| ID | Head Gene | Tail Gene | Accession | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a |
| Other DBs for Structural Variants |
| Top |
| Copy Number Variations in COSMIC: go to COSMIC mutation CNV/Expr |
| There's no copy number variation information in COSMIC data for this gene. |
| Top |
| SNV Counts per Each Loci in COSMIC data: go to COSMIC point mutation |
|
: Non-synonymous mutation, 
: Synonymous mutation, Circle size denotes number of samples. |
| Top |
| Somatic Mutation Counts per Tissue in COSMIC data |
| Stat. for Non-Synonymous SNVs (# total SNVs=12) | (# total SNVs=3) |
 |  |
(# total SNVs=0) | (# total SNVs=0) |
| Top |
| Top 10 SNVs Having the Most Samples in COSMIC data |
| * When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site,primary_histology,mutation(aa),pubmedID. |
| GRCh37 position | Mutation(aa) | Unique sampleID count |
| chr2:242625197-242625197 | p.R76C | 1 |
| chr2:242617978-242617978 | p.D139E | 1 |
| chr2:242625211-242625211 | p.L71P | 1 |
| chr2:242618025-242618025 | p.L124I | 1 |
| chr2:242625274-242625274 | p.G50D | 1 |
| chr2:242618032-242618032 | p.D121D | 1 |
| chr2:242626180-242626180 | p.A7S | 1 |
| chr2:242618050-242618050 | p.D115D | 1 |
| chr2:242626193-242626193 | p.A2A | 1 |
| chr2:242618072-242618072 | p.? | 1 |
| Top |
| SNV Counts per Each Loci in TCGA data |
|
 |
| Point Mutation/ Tissue ID | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| # sample | 1 | 2 | 1 | 1 | 1 | 2 | ||||||||||||||
| # mutation | 1 | 2 | 1 | 1 | 1 | 2 | ||||||||||||||
| nonsynonymous SNV | 1 | 1 | 1 | 1 | 1 | 2 | ||||||||||||||
| synonymous SNV | 1 |
| cf) Tissue ID; Tissue type (1; BLCA[Bladder Urothelial Carcinoma], 2; BRCA[Breast invasive carcinoma], 3; CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], 4; COAD[Colon adenocarcinoma], 5; GBM[Glioblastoma multiforme], 6; Glioma Low Grade, 7; HNSC[Head and Neck squamous cell carcinoma], 8; KICH[Kidney Chromophobe], 9; KIRC[Kidney renal clear cell carcinoma], 10; KIRP[Kidney renal papillary cell carcinoma], 11; LAML[Acute Myeloid Leukemia], 12; LUAD[Lung adenocarcinoma], 13; LUSC[Lung squamous cell carcinoma], 14; OV[Ovarian serous cystadenocarcinoma ], 15; PAAD[Pancreatic adenocarcinoma], 16; PRAD[Prostate adenocarcinoma], 17; SKCM[Skin Cutaneous Melanoma], 18:STAD[Stomach adenocarcinoma], 19:THCA[Thyroid carcinoma], 20:UCEC[Uterine Corpus Endometrial Carcinoma]) |
| Top |
| Top 10 SNVs Having the Most Samples in TCGA data |
| * We represented just top 10 SNVs. When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site, primary_histology, mutation(aa), pubmedID. |
| Genomic Position | Mutation(aa) | Unique sampleID count |
| chr2:242617982 | p.G50D,DTYMK | 1 |
| chr2:242619715 | p.A2A,DTYMK | 1 |
| chr2:242625274 | p.R168H,DTYMK | 1 |
| chr2:242626193 | p.R126H,DTYMK | 1 |
| chr2:242615606 | p.H124N,DTYMK | 1 |
| chr2:242617946 | p.R119L,DTYMK | 1 |
| chr2:242617953 | p.A114V,DTYMK | 1 |
| chr2:242617967 | p.L87M,DTYMK | 1 |
| Other DBs for Point Mutations |
| Copy Number for DTYMK in TCGA |
| * Copy number data were extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered on Jan-05-2015. Function ProcessCNAData in TCGA-Assembler package was used to obtain gene-level copy number value which is calculated as the average copy number of the genomic region of a gene. |
 |
| cf) Tissue ID[Tissue type]: BLCA[Bladder Urothelial Carcinoma], BRCA[Breast invasive carcinoma], CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], COAD[Colon adenocarcinoma], GBM[Glioblastoma multiforme], Glioma Low Grade, HNSC[Head and Neck squamous cell carcinoma], KICH[Kidney Chromophobe], KIRC[Kidney renal clear cell carcinoma], KIRP[Kidney renal papillary cell carcinoma], LAML[Acute Myeloid Leukemia], LUAD[Lung adenocarcinoma], LUSC[Lung squamous cell carcinoma], OV[Ovarian serous cystadenocarcinoma ], PAAD[Pancreatic adenocarcinoma], PRAD[Prostate adenocarcinoma], SKCM[Skin Cutaneous Melanoma], STAD[Stomach adenocarcinoma], THCA[Thyroid carcinoma], UCEC[Uterine Corpus Endometrial Carcinoma] |
| Top |
| Gene Expression for DTYMK |
| Gene Expression in Cancer Cell-lines (CCLE) |
| * CCLE gene expression data were extracted from CCLE_Expression_Entrez_2012-10-18.res: Gene-centric RMA-normalized mRNA expression data. |
 |
| Differential Gene Expression in Primary Tumors (TCGA) |
| * Normalized gene expression data of RNASeqV2 was extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered at Jan-05-2015. Only eight cancer types have enough normal control samples for differential expression analysis. (t test, adjusted p<0.05 (using Benjamini-Hochberg FDR)) |
 |
| Top |
| CNV vs Gene Expression Plot |
| * This plots show the correlation between CNV and gene expression. |
: Open all plots for all cancer types
 |
|
 |
|
| Top |
| Gene-Gene Network Information |
| Co-Expressed gene's network Plot |
| * Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
: Open all plots for all cancer types
 |
| ||||
| ANAPC11,AP2S1,ATG4B,ATG101,C14orf80,CCDC124,DAZAP1, DTYMK,ILKAP,LSM4,LSM7,MXD3,NDUFA11,NDUFB7, NDUFS6,PLEKHJ1,PTGES2,RPS19BP1,STK25,THAP4,TIMM13 | ARF5,BCL7C,BRMS1,C9orf16,CHID1,COPE,DTYMK, FIBP,GNB2,ITPA,MPG,NUDT1,PPIB,PPP1CA, PPP4C,PSMG3,PYCARD,RALY,SLC25A39,TMEM208,ZDHHC12 | ||||
 |
| ||||
| BIRC5,CKS1B,DTYMK,EPR1,GINS2,H2AFZ,ILKAP, LSM2,LSM4,MRPL11,MYEOV2,NME1,RFC2,RFC4, RNASEH2A,SNRPG,SPC25,STRA13,TIMM8B,TRAIP,UBE2T | BOLA3,PARPBP,C1QBP,CDKN3,CHEK2,CKS2,DTYMK, EBNA1BP2,GINS1,GINS2,HMBS,KIAA0101,MAD2L1,MRPS16, NUP37,POP5,PPIH,RAN,SNRNP40,SNRPB,UBE2T |
| Co-Expressed gene's Protein-protein interaction Network Plot |
| * Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
: Open all plots for all cancer types
| Top |
| Interacting Genes (from Pathway Commons) |
: Open all interacting genes' information including KEGG pathway for all interacting genes from DAVID
| Top |
| Pharmacological Information for DTYMK |
| Cross-referenced pharmacological DB IDs from Uniprot |
| DB Category | DB Name | DB's ID and Url link |
| Drug-Gene Interaction Network |
| * Gene Centered Interaction Network. |
 |
| * Drug Centered Interaction Network. |
| DrugBank ID | Target Name | Drug Groups | Generic Name | Drug Centered Network | Drug Structure |
| DB00130 | deoxythymidylate kinase (thymidylate kinase) | approved; nutraceutical; investigational | L-Glutamine |  |  |
| DB00495 | deoxythymidylate kinase (thymidylate kinase) | approved | Zidovudine |  |  |
| Top |
| Cross referenced IDs for DTYMK |
| * We obtained these cross-references from Uniprot database. It covers 150 different DBs, 18 categories. http://www.uniprot.org/help/cross_references_section |
: Open all cross reference information
|
Copyright © 2016-Present - The Univsersity of Texas Health Science Center at Houston @ |